These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 4624276

  • 41. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
    Newman R, Doster B, Murray FJ, Ferebee S.
    Am Rev Respir Dis; 1971 Apr; 103(4):461-76. PubMed ID: 4994459
    [No Abstract] [Full Text] [Related]

  • 42. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
    Nitti V.
    Scand J Respir Dis Suppl; 1973 Apr; 84():180-5. PubMed ID: 4593266
    [No Abstract] [Full Text] [Related]

  • 43. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1974 Nov 09; 2(7889):1100-6. PubMed ID: 4139405
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Preliminary results with rifampicin in the treatment of drug-resistant tuberculosis.
    Pines A.
    Tubercle; 1969 Mar 09; 50():Suppl:50-2. PubMed ID: 5402545
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Diagnosis and management of tuberculosis.
    Harris AA, Karakusis P.
    Prim Care; 1979 Mar 09; 6(1):43-62. PubMed ID: 111269
    [No Abstract] [Full Text] [Related]

  • 48. [Results of intermittent treatment of tuberculosis and Mycobacteria shedding in children].
    Rudnik J, Majewska-Zalewska H.
    Pediatr Pol; 1983 Dec 09; 58(12):941-55. PubMed ID: 6422437
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov 09; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.
    Dutt AK, Moers D, Stead WW.
    Am J Med; 1984 Aug 09; 77(2):233-42. PubMed ID: 6431810
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Anatomic and bacteriologic testing of rifampicin effectiveness in treatment of pulmonary tuberculosis].
    Morère P, Stain JP, Hubert J, Chauvet MC.
    Rev Tuberc Pneumol (Paris); 1970 Aug 09; 34(3):434-8. PubMed ID: 4994941
    [No Abstract] [Full Text] [Related]

  • 55. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W, Krawczyk Z, Górnicka-Wilczyńska M, Pilarska-Machowicz A, Pruszyńska S, Pawlik J, Wardowa A, Woźniak B, Tomaszkiewicz L.
    Pneumonol Pol; 1980 Nov 09; 48(11):663-8. PubMed ID: 7255206
    [No Abstract] [Full Text] [Related]

  • 56. Tuberculosis in Acukland.
    Swinburn PD.
    N Z Med J; 1973 Dec 26; 78(505):520-5. PubMed ID: 4205888
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.